Small Volume Injectables Methylene Blue Injection
Secured the FDA approval letter on December 23, 2025, achieving U.S. marketing approval. FDA-approved indication: the treatment of pediatric and adult patients with acquired methemoglobinemia.
Chengdu Shuode Pharmaceutical Co., Ltd.